Pluri Inc. — Director's Dealing 2020

Jun 29, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2020-05-27

Reporting Person: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2511311	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Warrant	$7	2024-04-08	Common Stock (47143)		Direct

Footnotes

F1: Reflects the 1-for-10 reverse stock split effected by Pluristem Therapeutics Inc. on July 25, 2019.